DEBORAH SWEET: Open Payments
NPI 1184818478 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 26 payments from 9 companies in 2025. Trend: 2023 $115 · 2024 $891 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $262 |
| Genentech USA, Inc. | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $90 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| BioCryst US Sales Co., LLC | 1 | $24 |
| CSL Behring | 1 | $24 |
| Grifols USA, LLC | 1 | $22 |
| Ionis Pharmaceuticals, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $16 |
Products named: TEZSPIRE, Xolair, FASENRA, TAKHZYRO, CUVITRU, NEFFY, ORLADEYO, Hizentra.
Industry payments across CO — which companies pay providers there.
